Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nuvectra Corporation (NASDAQ: NVTR).

Full DD Report for NVTR

You must become a subscriber to view this report.


Recent News from (NASDAQ: NVTR)

Nuvectra Receives FDA Head-Only MR-Conditional Approval for Algovita®
PLANO, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) head-only MR-conditional approval for the Company’s Algovita SCS system. Sco...
Source: GlobeNewswire
Date: December, 03 2018 08:01
Best Performing Stocks YTD 2018
There are 66 stocks in the Russell 3,000 that are up more than 100% year-to-date in 2018. Below is a list of the 40 best performers. As shown, three stocks - NII Holdings (NIHD), Tandem Diabetes (TNDM), and Turtle Beach (HEAR) - are up 1,000%+ year-to-date, meaning they've recorded "10-baggers...
Source: SeekingAlpha
Date: November, 07 2018 03:12
Nuvectra® to Participate in Two Upcoming Investor Conferences
PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate i...
Source: GlobeNewswire
Date: October, 31 2018 08:01
Book Build Alert: Axonics Modulation Readies IPO In Challenging Market
Quick Take The Axonics Modulation ( AXNX ) IPO is indicating significant demand according to IPO information service IPO Boutique. Axonics sells a sacral neuromodulation system for the treatment of several urinary conditions. Although life science firms may be somewhat less affected by s...
Source: SeekingAlpha
Date: October, 30 2018 13:11
Nuvectra Corporation (NVTR) CEO Scott Drees on Q3 2018 Results - Earnings Call Transcript
Nuvectra Corporation (NVTR) Q3 2018 Earnings Conference Call October 29, 2018 4:30 P.M. ET Executives Tram Bui - The Ruth Group Scott Drees - Chief Executive Officer Walter Berger - Chief Operating Officer and Chief Financial Officer Analysts Matthew O'Brien - Piper Jaffray...
Source: SeekingAlpha
Date: October, 29 2018 23:03
Nuvectra Corporation beats by $0.04, beats on revenue
Nuvectra Corporation (NASDAQ: NVTR ): Q3 GAAP EPS of -$0.87 beats by $0.04 . More news on: Nuvectra Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 29 2018 16:07
Nuvectra® Reports Third Quarter 2018 Financial Results
Reports Record Algovita ® Sales of $12.5 million, Up 98% YoY PLANO, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the third quarter ended September 30, 2018. Hig...
Source: GlobeNewswire
Date: October, 29 2018 16:01
Axonics Modulation Technologies Proposes Terms For $100 Million IPO
Quick Take Axonics Modulation Technologies ( AXNX ) intends to raise $100 million from the sale of its common stock in an IPO, per an amended registration statement . The company is developing a sacral neuromodulation device to treat a number of urinary tract conditions. AXNX is neari...
Source: SeekingAlpha
Date: October, 23 2018 12:01
Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018
PLANO, Texas, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the third quarter ended September 30, 2018 on Monday, October 29, 2018 after market close. Nuvectr...
Source: GlobeNewswire
Date: October, 22 2018 08:01
Axonics Modulation Seeks $86 Million In U.S. IPO
Quick Take Axonics Modulation Technologies ( AXNX ) intends to raise gross proceeds of $86.25 million from a U.S. IPO, according to an S-1 registration statement . The firm develops and commercializes minimally invasive sacral neuromodulation (SNM) solutions. AXNX hopes to raise publi...
Source: SeekingAlpha
Date: October, 18 2018 12:16

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0822.7821.9923.1821.8587,282
2018-05-1716.8717.4317.7516.82145,721
2017-08-1711.9011.6912.0411.6516,058
2017-08-1611.7611.9212.1711.7648,765
2017-08-1512.04511.7312.04511.6737,795

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1212,51520,14562.1246Short
2018-12-1121,07230,35269.4254Short
2018-12-109,25819,17948.2715Short
2018-12-079,40427,98433.6049Cover
2018-12-0627,05360,08445.0253Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NVTR.


About Nuvectra Corporation (NASDAQ: NVTR)

Logo for Nuvectra Corporation (NASDAQ: NVTR)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $236,784,793 - 05/11/2018
  • Issue and Outstanding: 14,153,305 - 04/26/2018

 


Recent Filings from (NASDAQ: NVTR)

Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 06 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 21 2018

 

 


Daily Technical Chart for (NASDAQ: NVTR)

Daily Technical Chart for (NASDAQ: NVTR)


Stay tuned for daily updates and more on (NASDAQ: NVTR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NVTR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NVTR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NVTR and does not buy, sell, or trade any shares of NVTR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/